Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03584386 · ClinicalTrials.gov registry record · NA

CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention

A NA study, sponsored by Evidence-Based Practice Institute, Seattle, WA.

Completed
Registry status
NA
Development phase
357
Enrollment target

NCT03584386: Completed NA study, sponsored by Evidence-Based Practice Institute, Seattle, WA.

NCT03584386 is a NA study that has completed, run by Evidence-Based Practice Institute, Seattle, WA. The registered enrollment target is 357 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03584386, a NA study, has completed, sponsored by Evidence-Based Practice Institute, Seattle, WA.

COMPLETED
Registry status
NA
Development phase
357 participants
Enrollment target

Study Summary

This Phase II study is a continuation of the Phase I feasibility study where the investigators fully met and exceeded project aims to design, build, and test the usability and acceptability of an avatar-based system, the Virtual-CAMS (V-CAMS, formerly called CAMS-RAS), for use by suicidal ED patients and medical personnel responsible for their care. Phase II includes a formative phase, during which the investigators will continue conducting usability and acceptability tests of new features, and a summative phase to conduct a clinical trial. SBIR Phase II project aims include: (1) Complete development of V-CAMS, including readiness for electronic health record integration; (2) Cultivate and utilize the advisory board so that V-CAMS is positioned to meet the needs of diverse healthcare systems and successful conduct of the proposed research; (3) Conduct usability/acceptability tests of new features with target end-users (suicidal patients, including those in the ED, medical providers) and key stakeholders (i.e., administrators); and (4) Conduct a randomized controlled trial (RCT; N=90) of suicidal ED patients comparing V-CAMS (n=45) to Care-As-Usual (CAU; n=45). Participants will be assessed at baseline while in the ED, and again at 7, 30, and 90 days. The investigators predict that V-CAMS participants will report a significantly greater decrease in suicidal behaviors and ED/hospital admissions, as well as significantly greater increases in use of behavioral coping skills, self-efficacy in coping with distress, and perceived helpfulness of patients' ED experience and satisfaction with the app. This study, however, was paused due to COVID after February, 2020 with a total of 31 participants recruited. The study later resumed at one site; however, because of COVID there were fewer admissions for suicidal behavior to the ED, only 7 participants were enrolled before the study ended recruitment in December, 2020. V-CAMS is now known as Jaspr Health ("Jaspr"). A telehealth

Primary Outcome

An 18-item psychometrically sound self-report measure, the Suicide Cognitions Scale (SCS) assesses suicidal schemas. The score is found by summing the items for a total ranging from 18 to 90 with higher scores indicating worse outcomes. The scale is administered to patient participants at four time-points during Phase II (summative) ED RCT and Telehealth RCT to assess change over time.

Interventions

  • DEVICE V-CAMS (aka Jaspr)

Trial Details

FieldValue
Enrollment Target 357 participants
Start Date 2018-10-01
Est. Completion 2021-03-31
Phase NA

What the finished NCT03584386 record still lists

NCT03584386 is an interventional study that assigns participants to a tested intervention. The registered 357 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 0 conditions, and to 1 intervention - of which V-CAMS (aka Jaspr) is the first listed.

NCT03584386 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03584386 about?

NCT03584386 is a clinical study titled "CAMS Relational Agent System (CAMS-RAS) for Suicide Prevention". This Phase II study is a continuation of the Phase I feasibility study where the investigators fully met and exceeded project aims to design, build, and test the usability and acceptability of an avatar-based system, the Virtual-CAMS (V-CAMS, formerly called CAMS-RAS), for use by suicidal ED patient...

What is the current status of trial NCT03584386?

This trial is currently completed. It is a NA study. The enrollment target is 357 participants. The study started on 2018-10-01. Estimated completion is 2021-03-31.

What interventions are being tested in trial NCT03584386?

The interventions under investigation include: V-CAMS (aka Jaspr) (DEVICE).

Who is sponsoring clinical trial NCT03584386?

This trial is sponsored by Evidence-Based Practice Institute, Seattle, WA, which has 7 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03584386's enrollment target sits among peer trials

357 289th of 2000 higher than 1,710 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06062888 · 357 participants · Phase 2

    FFP In Traumatic BRAin INjury (FIT-BRAIN) Trial

  • NCT06109766 · 357 participants · NA

    Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth

  • NCT06231342 · 357 participants · NA

    Endotracheal Tube (ETT) 180: Stylet-loaded Endotracheal Tube Rotation Before Insertion

  • NCT06533826 · 357 participants · Phase 2

    TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXd

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03584386, the US trial registry maintained by the National Library of Medicine. NCT03584386 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.